LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $815,000 | -15.9% | 8,550 | -1.3% | 0.04% | -17.0% |
| Q2 2020 | $969,000 | +48.2% | 8,660 | -3.7% | 0.05% | +27.0% |
| Q1 2020 | $654,000 | -30.2% | 8,989 | 0.0% | 0.04% | +5.7% |
| Q4 2019 | $937,000 | +2.3% | 8,989 | -2.3% | 0.04% | -7.9% |
| Q3 2019 | $916,000 | -13.0% | 9,203 | -0.2% | 0.04% | -7.3% |
| Q2 2019 | $1,053,000 | -9.5% | 9,224 | -0.3% | 0.04% | -12.8% |
| Q1 2019 | $1,163,000 | +11.1% | 9,251 | +19.8% | 0.05% | +113.6% |
| Q4 2018 | $1,047,000 | – | 7,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |